Nifty
Sensex
:
:
22957.10
75410.39
-10.55 (-0.05%)
-7.65 (-0.01%)

Pharmaceuticals & Drugs

Rating :
54/99

BSE: 507789 | NSE: JAGSNPHARM

332.15
23-May-2024
  • Open
  • High
  • Low
  • Previous Close
  •  344.65
  •  348.00
  •  329.90
  •  343.80
  • Volume
  • Traded Value (lacs)
  • 52 Week High
  • 52 Week Low
  •  23119
  •  78.03
  •  514.85
  •  273.60

Stock Summary

  • Market Cap(Crs)
  • Stock P:E
  • Face Value
  • 881.27
  • 39.23
  • 5
  • Enterprise Value(Crs)
  • Dividend Yield
  • Price:Book Value
  • 733.34
  • 1.50%
  • 4.70

Shareholding Pattern

  • Promoter
  • Corporate
  • Public
  • 68.09%
  • 3.54%
  • 20.68%
  • FII
  • DII
  • Others
  • 0.73%
  • 0.00%
  • 6.96%

Chart

Price | P:E | P:BV | EV:EBITDA | MCap:Sales | EPS

Revenue CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • 5.11
  • 7.25
  • 7.99

EBITDA CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • 12.33
  • 29.60
  • 12.35

PAT CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • 28.84
  • 29.92
  • 16.13

P:E (Median)

  • 8 Years
  • 5 Years
  • 3 Years
  • 18.80
  • 20.98
  • 35.63

P:BV (Average)

  • 8 Years
  • 5 Years
  • 3 Years
  • 4.38
  • 4.38
  • 5.69

EV:EBITDA (Average)

  • 8 Years
  • 5 Years
  • 3 Years
  • 278.10
  • 15.89
  • 22.45

Quarterly Results

Standalone Figures in Rs. Crores /

Consolidated
Description
Dec 23
Dec 22
Var%
Sep 23
Sep 22
Var%
Jun 23
Jun 22
Var%
Mar 23
Mar 22
Var%
Net Sales
0.00
0.00
0
0.00
0.00
0
0.00
0.00
0
0.00
0.00
0
Expenses
0.00
0.00
0
0.00
0.00
0
0.00
0.00
0
0.00
0.00
0
EBITDA
0.00
0.00
0
0.00
0.00
0
0.00
0.00
0
0.00
0.00
0
EBIDTM
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
Other Income
0.00
0.00
0
0.00
0.00
0
0.00
0.00
0
0.00
0.00
0
Interest
0.00
0.00
0
0.00
0.00
0
0.00
0.00
0
0.00
0.00
0
Depreciation
0.00
0.00
0
0.00
0.00
0
0.00
0.00
0
0.00
0.00
0
PBT
0.00
0.00
0
0.00
0.00
0
0.00
0.00
0
0.00
0.00
0
Tax
0.00
0.00
0
0.00
0.00
0
0.00
0.00
0
0.00
0.00
0
PAT
0.00
0.00
0
0.00
0.00
0
0.00
0.00
0
0.00
0.00
0
PATM
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
EPS
0.00
0.00
0
0.00
0.00
0
0.00
0.00
0
0.00
0.00
0

Annual Results

Standalone Figures in Rs. Crores

Results Balance Sheet

Standalone Figures in Rs. Crores

Cash Flow

Standalone Figures in Rs. Crores

Financial Ratios

Standalone

News Update:


  • Jagsonpal Pharmaceutical launches India’s first hormone replacement therapy ‘MemUp’
    24th May 2024, 09:27 AM

    MemUp is designed to specifically address this gap and support the urgent need for innovative and effective treatments

    Read More
  • Jagsonpal Pharmaceuticals launches ‘QueeZy-ER’
    9th Mar 2024, 14:45 PM

    The product combines proven efficacy of Doxylamine succinate 20 mg and Pyridoxine hydrochloride 20 mg in an Extended Release formulation

    Read More
  • Jagsonpal Pharmaceutical launches QueeZy-ER
    8th Mar 2024, 16:54 PM

    Queezy-ER is now available in leading pharmacies across India

    Read More

Source: www.accordfintech.com | DISCLAIMER: Information is provided " as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed.